1. Home
  2. BDTX vs MTN Comparison

BDTX vs MTN Comparison

Compare BDTX & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • MTN
  • Stock Information
  • Founded
  • BDTX 2014
  • MTN 1997
  • Country
  • BDTX United States
  • MTN United States
  • Employees
  • BDTX N/A
  • MTN N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MTN Services-Misc. Amusement & Recreation
  • Sector
  • BDTX Health Care
  • MTN Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • MTN Nasdaq
  • Market Cap
  • BDTX 220.3M
  • MTN 6.1B
  • IPO Year
  • BDTX 2020
  • MTN 1997
  • Fundamental
  • Price
  • BDTX $3.87
  • MTN $145.45
  • Analyst Decision
  • BDTX Strong Buy
  • MTN Buy
  • Analyst Count
  • BDTX 5
  • MTN 9
  • Target Price
  • BDTX $10.40
  • MTN $176.78
  • AVG Volume (30 Days)
  • BDTX 832.2K
  • MTN 635.5K
  • Earning Date
  • BDTX 11-05-2025
  • MTN 12-08-2025
  • Dividend Yield
  • BDTX N/A
  • MTN 6.11%
  • EPS Growth
  • BDTX N/A
  • MTN 23.64
  • EPS
  • BDTX 0.25
  • MTN 7.53
  • Revenue
  • BDTX $70,000,000.00
  • MTN $2,964,347,000.00
  • Revenue This Year
  • BDTX N/A
  • MTN $2.72
  • Revenue Next Year
  • BDTX N/A
  • MTN $3.48
  • P/E Ratio
  • BDTX $15.46
  • MTN $19.32
  • Revenue Growth
  • BDTX N/A
  • MTN 2.74
  • 52 Week Low
  • BDTX $1.20
  • MTN $129.85
  • 52 Week High
  • BDTX $4.45
  • MTN $199.45
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 52.23
  • MTN 44.36
  • Support Level
  • BDTX $3.62
  • MTN $141.85
  • Resistance Level
  • BDTX $3.97
  • MTN $149.84
  • Average True Range (ATR)
  • BDTX 0.22
  • MTN 4.36
  • MACD
  • BDTX -0.05
  • MTN -0.80
  • Stochastic Oscillator
  • BDTX 45.45
  • MTN 22.05

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: